THE RELEVANCE, BENEFITS AND CLINICAL PERSPECTIVES OF THE COMBINED TREATMENT OF OSTEOPOROSIS BASED ON BONE-ANABOLIC THERAPY

Остеопороз и остеопатии

L A Marchenkova¹  E Yu Martynova¹ 

[1] ФГБУ «Российский научный центр медицинской реабилитации и курортологии» Минздрава России;

关键词: остеопороз;    терипаратид;    комбинированная терапия;    последовательная терапия;   

DOI  :  10.14341/osteo2015220-24

来源: DOAJ

【 摘 要 】

Combination therapy of osteoporosis based on bone-anabolic and antiresorbtive agents has a great clinical perspective. An analysis of available publications shows that combination therapy is appropriate from the standpoint of increasing the effectiveness of treatment. Combination therapy can be executed as a simultaneous use of teriparatide with denosumab, raloxifene or hormonal therapy, and the subsequent administration of bisphosphonates, denosumab or raloxifene after treatment with teriparatide. The review presents the evidence-based data on the effect of combined and sequential regimens for osteoporosis fracture risk.

【 授权许可】

Unknown